High Sensitive C-reactive Protein to Albumin Ratio in Acute Coronary Syndrome

NCT06673381 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2024-11-04

No results posted yet for this study

Summary

assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Amira Elbasuony, resident · Sohag University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2024-11-01
Completion
2025-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06673381 on ClinicalTrials.gov